Other authors proved that the lncRNA ZEB2-AS1 was overexpressed in NSCLC patients, which stimulated the epithelial-mesenchymal transition (EMT) in these patients, proving that lncRNA ZEB2-AS1 may become a new diagnostic, prognostic and therapeutic factor (108). Here, ZEB2 is linked to non-small cell lung carcinoma.